Acino International AG’s Acquisition of Six Prescription Medicines from Aspen Pharmacare Holdings Limited’s Operations in South Africa for ZAR 1.8 billion

Lead party: Acino International AG (lead investor/buyer)Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed). Target: South African Prescription Medicines Transaction type: Merger/Acquisition(M&A) · Asset class: Corporate Transactions · Strategy: Bolt-On · Instrument: Equity · Deal amount: US$123.2m · Equity stake: 1% · Implied EV: US$123.2m Lead investor/buyer: Acino International AG…


Lead party: Acino International AG (lead investor/buyer)

Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed).

Target: South African Prescription Medicines

Transaction type: Merger/Acquisition(M&A) · Asset class: Corporate Transactions · Strategy: Bolt-On · Instrument: Equity · Deal amount: US$123.2m · Equity stake: 1% · Implied EV: US$123.2m

Lead investor/buyer: Acino International AG · Investors/buyers: Acino International AG

Legal advisers: not identified in the source record.

Source: announced 22 October 2021. Original announcement: acino.swiss.